About Nitroplus Nitro-glycerin 25MG injection
| Brand Name |
Nitroplus 25MG injection
|
| Manufacturer |
Neon Laboratories Ltd
|
| Dose |
25mg
|
| Packaging Type |
VIAL
|
| Packaging Size |
5ml
|
| Composition |
Nitroglycerin 25mg
|
| Usage/Application |
Angina (heart-related chest pain)
|
Introduction of Nitroplus 25mg injection :
Nitroplus 25mg Injection is utilized to treat and forestall heart-related chest torment (angina). Angina happens when the heart muscle isn't getting sufficient blood. This medication works by unwinding and extending veins so blood can stream all the more effectively to the heart. It makes an exceptionally brief difference.
Precise Relief for Cardiac EmergenciesNitroplus injection delivers nitroglycerin directly into the bloodstream for immediate management of angina, perioperative blood pressure control, and acute heart failure. Its fast-acting formulation benefits adults requiring urgent intervention. Dosage is tailored by the physician, ensuring both effectiveness and safety are prioritized according to clinical needs.
Dedicated Administration and MonitoringNitroplus is intended strictly for slow IV infusion, necessitating close blood pressure monitoring throughout administration. The solution must be diluted before use and given as directed by a healthcare professional. This careful process minimizes risks such as hypotension and other adverse effects, promoting optimal outcomes.
Reliable Pharmaceutical QualityManufactured by Troikaa Pharmaceuticals Ltd., Nitroplus adheres to stringent quality standards. Each ampoule contains 25 mg nitroglycerin in a clear, colorless solution, with five ampoules per box. Shelf life is 24 months, and proper storage safeguards the medication's efficacy until use.
FAQ's of Nitroplus Nitro-glycerin 25MG injection:
Q: How should Nitroplus Nitro-glycerin 25MG injection be administered?
A: Nitroplus must be diluted before use and then given as a slow intravenous (IV) infusion by a healthcare professional. Continuous blood pressure monitoring is required during administration to ensure patient safety.
Q: What conditions is Nitroplus injection recommended for?
A: Nitroplus is prescribed for adults to manage acute angina pectoris, control blood pressure in the perioperative period, treat acute decompensated heart failure, and alleviate hypertension.
Q: When should Nitroplus injection not be used?
A: Nitroplus is contraindicated in individuals with severe anemia, hypotension, increased intracranial pressure, or hypersensitivity to nitroglycerin. A thorough medical assessment is required prior to administration.
Q: Where should Nitroplus injection be stored?
A: Nitroplus ampoules should be stored below 25C and protected from light to maintain their efficacy. Always check the expiry date before use.
Q: What is the typical process for using Nitroplus injection?
A: Upon prescription, the solution is diluted and administered by slow IV infusion. The initial dose is usually 5 mcg/min, adjusted by the physician based on blood pressure response and clinical need.
Q: Are there any side effects associated with Nitroplus injection?
A: Common side effects include headache, hypotension, dizziness, and tachycardia. Immediate medical attention is required if adverse reactions occur during infusion.
Q: What are the main benefits of using Nitroplus injection?
A: Nitroplus offers rapid vasodilation, which helps relieve angina attacks, control perioperative blood pressure, and improve cardiac function in heart failure, providing effective and timely intervention for critical care situations.